Software - Application
Compare Stocks
5 / 10Stock Comparison
CWAN vs VRNT vs MKTX vs ICE vs MSCI
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Financial - Capital Markets
Financial - Data & Stock Exchanges
Financial - Data & Stock Exchanges
CWAN vs VRNT vs MKTX vs ICE vs MSCI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Software - Infrastructure | Financial - Capital Markets | Financial - Data & Stock Exchanges | Financial - Data & Stock Exchanges |
| Market Cap | $7.21B | $1.24B | $5.43B | $88.45B | $42.83B |
| Revenue (TTM) | $826M | $894M | $849M | $12.64B | $3.13B |
| Net Income (TTM) | $-48M | $61M | $310M | $3.30B | $1.32B |
| Gross Margin | 66.0% | 69.9% | 69.9% | 61.9% | 82.4% |
| Operating Margin | 1.4% | 8.6% | 41.2% | 38.7% | 54.7% |
| Forward P/E | 34.6x | 7.0x | 18.6x | 19.5x | 30.0x |
| Total Debt | $883M | $448M | $285M | $20.28B | $6.31B |
| Cash & Equiv. | $91M | $216M | $520M | $837M | $515M |
CWAN vs VRNT vs MKTX vs ICE vs MSCI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Clearwater Analytic… (CWAN) | 100 | 94.8 | -5.2% |
| Verint Systems Inc. (VRNT) | 100 | 45.3 | -54.7% |
| MarketAxess Holding… (MKTX) | 100 | 36.3 | -63.7% |
| Intercontinental Ex… (ICE) | 100 | 136.0 | +36.0% |
| MSCI Inc. (MSCI) | 100 | 96.7 | -3.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CWAN vs VRNT vs MKTX vs ICE vs MSCI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CWAN ranks third and is worth considering specifically for growth exposure.
- Rev growth 61.9%, EPS growth -108.3%, 3Y rev CAGR 34.1%
- 61.9% revenue growth vs VRNT's -0.1%
VRNT has the current edge in this matchup, primarily because of its strength in valuation efficiency.
- PEG 0.36 vs MKTX's 3.03
- Lower P/E (7.0x vs 30.0x), PEG 0.36 vs 1.77
- +17.9% vs MKTX's -31.7%
MKTX is the clearest fit if your priority is dividends.
- 2.0% yield, 12-year raise streak, vs ICE's 1.2%, (1 stock pays no dividend)
ICE is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 14 yrs, beta 0.33, yield 1.2%
- Lower volatility, beta 0.33, Low D/E 69.9%, current ratio 1.02x
- Beta 0.33, yield 1.2%, current ratio 1.02x
- Beta 0.33 vs VRNT's 1.26
MSCI is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 7.2% 10Y total return vs ICE's 225.3%
- 38.4% margin vs CWAN's -5.8%
- 24.0% ROA vs CWAN's -1.6%, ROIC 34.9% vs 1.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 61.9% revenue growth vs VRNT's -0.1% | |
| Value | Lower P/E (7.0x vs 30.0x), PEG 0.36 vs 1.77 | |
| Quality / Margins | 38.4% margin vs CWAN's -5.8% | |
| Stability / Safety | Beta 0.33 vs VRNT's 1.26 | |
| Dividends | 2.0% yield, 12-year raise streak, vs ICE's 1.2%, (1 stock pays no dividend) | |
| Momentum (1Y) | +17.9% vs MKTX's -31.7% | |
| Efficiency (ROA) | 24.0% ROA vs CWAN's -1.6%, ROIC 34.9% vs 1.1% |
CWAN vs VRNT vs MKTX vs ICE vs MSCI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CWAN vs VRNT vs MKTX vs ICE vs MSCI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MSCI leads in 1 of 6 categories
VRNT leads 1 • MKTX leads 1 • CWAN leads 0 • ICE leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MSCI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICE is the larger business by revenue, generating $12.6B annually — 15.3x CWAN's $826M. MSCI is the more profitable business, keeping 38.4% of every revenue dollar as net income compared to CWAN's -5.8%. On growth, CWAN holds the edge at +74.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $826M | $894M | $849M | $12.6B | $3.1B |
| EBITDAEarnings before interest/tax | $94M | $127M | $443M | $6.5B | $2.0B |
| Net IncomeAfter-tax profit | -$48M | $61M | $310M | $3.3B | $1.3B |
| Free Cash FlowCash after capex | $152M | $118M | $236M | $4.3B | $1.5B |
| Gross MarginGross profit ÷ Revenue | +66.0% | +69.9% | +69.9% | +61.9% | +82.4% |
| Operating MarginEBIT ÷ Revenue | +1.4% | +8.6% | +41.2% | +38.7% | +54.7% |
| Net MarginNet income ÷ Revenue | -5.8% | +6.9% | +29.0% | +26.1% | +38.4% |
| FCF MarginFCF ÷ Revenue | +18.5% | +13.2% | +44.0% | +33.9% | +49.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +74.4% | -1.0% | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -137.9% | -5.1% | +4.5% | +23.1% | +49.1% |
Valuation Metrics
VRNT leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 19.7x trailing earnings, VRNT trades at a 48% valuation discount to MSCI's 37.8x P/E. Adjusting for growth (PEG ratio), VRNT offers better value at 1.02x vs ICE's 3.05x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7.2B | $1.2B | $5.4B | $88.4B | $42.8B |
| Enterprise ValueMkt cap + debt − cash | $8.0B | $1.5B | $5.2B | $107.9B | $48.6B |
| Trailing P/EPrice ÷ TTM EPS | -173.50x | 19.72x | 22.92x | 27.06x | 37.81x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.60x | 7.00x | 18.63x | 19.48x | 29.99x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.02x | 3.03x | 3.05x | 2.23x |
| EV / EBITDAEnterprise value multiple | 70.39x | 9.46x | 11.96x | 16.71x | 25.17x |
| Price / SalesMarket cap ÷ Revenue | 9.85x | 1.37x | 6.39x | 7.00x | 13.67x |
| Price / BookPrice ÷ Book value/share | 3.24x | 0.97x | 4.85x | 3.08x | — |
| Price / FCFMarket cap ÷ FCF | 43.85x | 8.75x | 14.51x | 20.62x | 27.65x |
Profitability & Efficiency
MKTX leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MKTX delivers a 24.0% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-2 for CWAN. MKTX carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to ICE's 0.70x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs CWAN's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.4% | +4.6% | +24.0% | +11.6% | — |
| ROA (TTM)Return on assets | -1.6% | +2.8% | +15.3% | +2.3% | +24.0% |
| ROICReturn on invested capital | +1.1% | +5.3% | +18.1% | +7.5% | +34.9% |
| ROCEReturn on capital employed | +1.4% | +5.9% | +25.4% | +9.5% | +44.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 7 | 5 | 9 | 8 |
| Debt / EquityFinancial leverage | 0.43x | 0.34x | 0.25x | 0.70x | — |
| Net DebtTotal debt minus cash | $792M | $233M | -$235M | $19.4B | $5.8B |
| Cash & Equiv.Liquid assets | $91M | $216M | $520M | $837M | $515M |
| Total DebtShort + long-term debt | $883M | $448M | $285M | $20.3B | $6.3B |
| Interest CoverageEBIT ÷ Interest expense | 0.07x | 8.24x | 168.60x | 6.53x | 7.67x |
Total Returns (Dividends Reinvested)
Evenly matched — CWAN and MSCI each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ICE five years ago would be worth $14,335 today (with dividends reinvested), compared to $3,822 for MKTX. Over the past 12 months, VRNT leads with a +17.9% total return vs MKTX's -31.7%. The 3-year compound annual growth rate (CAGR) favors CWAN at 18.3% vs MKTX's -18.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +0.7% | — | -14.1% | -2.1% | +4.5% |
| 1-Year ReturnPast 12 months | +6.1% | +17.9% | -31.7% | -10.4% | +7.8% |
| 3-Year ReturnCumulative with dividends | +65.7% | -39.3% | -46.0% | +50.8% | +28.6% |
| 5-Year ReturnCumulative with dividends | -4.3% | -56.1% | -61.8% | +43.4% | +27.9% |
| 10-Year ReturnCumulative with dividends | -4.3% | -37.1% | +38.3% | +225.3% | +720.9% |
| CAGR (3Y)Annualised 3-year return | +18.3% | -15.3% | -18.6% | +14.7% | +8.7% |
Risk & Volatility
Evenly matched — CWAN and MKTX each lead in 1 of 2 comparable metrics.
Risk & Volatility
MKTX is the less volatile stock with a -0.28 beta — it tends to amplify market swings less than VRNT's 1.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CWAN currently trades 96.9% from its 52-week high vs MKTX's 65.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.80x | 1.26x | -0.28x | 0.33x | 0.61x |
| 52-Week HighHighest price in past year | $25.07 | $22.84 | $232.84 | $189.35 | $626.28 |
| 52-Week LowLowest price in past year | $15.74 | $16.23 | $146.00 | $143.17 | $501.08 |
| % of 52W HighCurrent price vs 52-week peak | +96.9% | +89.8% | +65.6% | +82.5% | +93.9% |
| RSI (14)Momentum oscillator 0–100 | 69.9 | 68.4 | 26.8 | 38.8 | 54.6 |
| Avg Volume (50D)Average daily shares traded | 4.0M | 0 | 456K | 3.0M | 520K |
Analyst Outlook
Evenly matched — MKTX and ICE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CWAN as "Hold", VRNT as "Hold", MKTX as "Hold", ICE as "Buy", MSCI as "Buy". Consensus price targets imply 58.8% upside for VRNT (target: $33) vs 2.8% for CWAN (target: $25). For income investors, MKTX offers the higher dividend yield at 2.05% vs MSCI's 1.22%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $24.96 | $32.57 | $195.60 | $195.71 | $674.33 |
| # AnalystsCovering analysts | 13 | 16 | 23 | 36 | 27 |
| Dividend YieldAnnual dividend ÷ price | — | +1.6% | +2.0% | +1.2% | +1.2% |
| Dividend StreakConsecutive years of raises | 1 | 0 | 12 | 14 | 11 |
| Dividend / ShareAnnual DPS | — | $0.32 | $3.13 | $1.93 | $7.20 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.3% | +5.8% | +7.7% | +1.6% | +5.8% |
MSCI leads in 1 of 6 categories (Income & Cash Flow). VRNT leads in 1 (Valuation Metrics). 3 tied.
CWAN vs VRNT vs MKTX vs ICE vs MSCI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CWAN or VRNT or MKTX or ICE or MSCI a better buy right now?
For growth investors, Clearwater Analytics Holdings, Inc.
(CWAN) is the stronger pick with 61. 9% revenue growth year-over-year, versus -0. 1% for Verint Systems Inc. (VRNT). Verint Systems Inc. (VRNT) offers the better valuation at 19. 7x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Intercontinental Exchange, Inc. (ICE) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CWAN or VRNT or MKTX or ICE or MSCI?
On trailing P/E, Verint Systems Inc.
(VRNT) is the cheapest at 19. 7x versus MSCI Inc. at 37. 8x. On forward P/E, Verint Systems Inc. is actually cheaper at 7. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Verint Systems Inc. wins at 0. 36x versus MarketAxess Holdings Inc. 's 3. 03x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CWAN or VRNT or MKTX or ICE or MSCI?
Over the past 5 years, Intercontinental Exchange, Inc.
(ICE) delivered a total return of +43. 4%, compared to -61. 8% for MarketAxess Holdings Inc. (MKTX). Over 10 years, the gap is even starker: MSCI returned +720. 9% versus VRNT's -37. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CWAN or VRNT or MKTX or ICE or MSCI?
By beta (market sensitivity over 5 years), MarketAxess Holdings Inc.
(MKTX) is the lower-risk stock at -0. 28β versus Verint Systems Inc. 's 1. 26β — meaning VRNT is approximately -548% more volatile than MKTX relative to the S&P 500. On balance sheet safety, MarketAxess Holdings Inc. (MKTX) carries a lower debt/equity ratio of 25% versus 70% for Intercontinental Exchange, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CWAN or VRNT or MKTX or ICE or MSCI?
By revenue growth (latest reported year), Clearwater Analytics Holdings, Inc.
(CWAN) is pulling ahead at 61. 9% versus -0. 1% for Verint Systems Inc. (VRNT). On earnings-per-share growth, the picture is similar: Verint Systems Inc. grew EPS 271. 4% year-over-year, compared to -108. 3% for Clearwater Analytics Holdings, Inc.. Over a 3-year CAGR, CWAN leads at 34. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CWAN or VRNT or MKTX or ICE or MSCI?
MSCI Inc.
(MSCI) is the more profitable company, earning 38. 4% net margin versus -5. 3% for Clearwater Analytics Holdings, Inc. — meaning it keeps 38. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MSCI leads at 54. 7% versus 3. 8% for CWAN. At the gross margin level — before operating expenses — MSCI leads at 82. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CWAN or VRNT or MKTX or ICE or MSCI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Verint Systems Inc. (VRNT) is the more undervalued stock at a PEG of 0. 36x versus MarketAxess Holdings Inc. 's 3. 03x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Verint Systems Inc. (VRNT) trades at 7. 0x forward P/E versus 34. 6x for Clearwater Analytics Holdings, Inc. — 27. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for VRNT: 58. 8% to $32. 57.
08Which pays a better dividend — CWAN or VRNT or MKTX or ICE or MSCI?
In this comparison, MKTX (2.
0% yield), VRNT (1. 6% yield), ICE (1. 2% yield), MSCI (1. 2% yield) pay a dividend. CWAN does not pay a meaningful dividend and should not be held primarily for income.
09Is CWAN or VRNT or MKTX or ICE or MSCI better for a retirement portfolio?
For long-horizon retirement investors, MarketAxess Holdings Inc.
(MKTX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 28), 2. 0% yield). Both have compounded well over 10 years (MKTX: +38. 3%, CWAN: -4. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CWAN and VRNT and MKTX and ICE and MSCI?
These companies operate in different sectors (CWAN (Technology) and VRNT (Technology) and MKTX (Financial Services) and ICE (Financial Services) and MSCI (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CWAN is a small-cap high-growth stock; VRNT is a small-cap quality compounder stock; MKTX is a small-cap quality compounder stock; ICE is a mid-cap quality compounder stock; MSCI is a mid-cap quality compounder stock. VRNT, MKTX, ICE, MSCI pay a dividend while CWAN does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.